Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
23 Results Found
RFID Solutions Attract Attention for Medication Inventory Management
More organizations are giving radio frequency identification (RFID) systems a second look to aid in medication management accuracy, safety and efficiency.
Mark Cuban Lays Out More Details about How He’s Disrupting Drug Pricing
Learn how Mark Cuban is disrupting drug pricing and making waves in the pharmaceutical industry. Find out more about his Cost Plus Drugs company and its collaborations with payers and pharmacists.
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future
Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand. Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.
Virtual Care Platform Wheel Expands Its Services, Focusing on Convenience
The virtual care platform Wheel recently made news by saying it would add mental health provider Talkspace, Mark Cuban’s Cost Plus Drug Company and the data-sharing program Health Gorilla into its integrated health care ecosystem this year.
Cost-Plus Drug Pricing Models Gain Momentum, but Will They Last?
CVS Health plans to launch its CVS CostVantage and CVS Caremark TrueCost programs in 2025. CostVantage will define the drug cost and related reimbursement with contracted PBMs and payers, CVS noted in a statement.
Will Blue Shield’s New Pharma Model Disrupt the PBM Market?
A new plan will transition Blue Shield of California’s drug supply management from CVS Health’s PBM to five companies — a move the payer believes will save its 4.8 million members as much as $500 million a year in drug costs or about 10% to 15% of what it spends on drugs annually.
Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.
3 Ways Pharma Could Jolt Health Care in 2023
The market for biosimilar drugs to treat cancer, inflammatory diseases, diabetes and more will continue to expand, ideally resulting in lower prices as more pharmaceutical patents expire and competitors enter the market.
The Latest Shakeup in the Prescription Drug Market: $5 Generics via Amazon Prime
Amazon Pharmacy steadily has been capturing business from large and small retail pharmacies, but its latest venture — RxPass —significantly could expand its customer base.
Mark Cuban Plots Next Move to Collaborate with Hospitals on Drug Shortages
Billionaire entrepreneur Mark Cuban had a simple mission when he established his Cost Plus Drugs venture in 2020 — to provide low-cost, high-quality pharmaceuticals to consumers.